Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
- Status
- COMPLETED
- Phase
- PHASE2
Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM
- Status
- COMPLETED
- Phase
- PHASE1
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
- Status
- COMPLETED
- Phase
- PHASE2
Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Ph I SU011248 + Irinotecan in Treatment of Pts w MG
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Ph I Dasatinib + Erlotinib in Recurrent MG
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2